Topics

Allergan plc Strategy, SWOT and Corporate Finance Report [Published by Marketline] Prices from USD $175

06:58 EDT 16 Aug 2019 | BioPortfolio Reports

Allergan plc Strategy, SWOT and Corporate Finance Report


Summary


Allergan plc Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360 view of the company.


Key Highlights


Allergan plc Allergan or 'the company' is a pharmaceutical company that develops, manufactures and markets branded pharmaceutical products, biologic, device, surgical and regenerative medicine products. The company offers products in various therapeutic areas, including central nervous system, eye care, medical aesthetics and dermatology, gastroenterology, women's health, urology and antiinfective therapeutic categories. Allergan sells its brand and aesthetic products to drug wholesalers, retailers and distributors, including national retail drug and food store chains, hospitals, clinics, mail order retailers, government agencies and managed healthcare providers such as health maintenance organizations and other institutions. It has business presence in the US, Europe, Asia and other regions of the world. The company is headquartered in Dublin, Ireland.


Scope


Detailed information on Allergan plc required for business and competitor intelligence needs

A study of the major internal and external factors affecting Allergan plc in the form of a SWOT analysis

An indepth view of the business model of Allergan plc including a breakdown and examination of key business segments

Intelligence on Allergan plc's mergers and acquisitions MandA, strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

News about Allergan plc, such as business expansion, restructuring, and contract wins

Large number of easytograsp charts and graphs that present important data and key trends


Reasons to buy


Gain understanding of Allergan plc and the factors that influence its strategies.

Track strategic initiatives of the company and latest corporate news and actions.

Assess Allergan plc as a prospective partner, vendor or supplier.

Support sales activities by understanding your customers' businesses better.

Stay up to date on Allergan plc's business structure, strategy and prospects.

Original Article: Allergan plc Strategy, SWOT and Corporate Finance Report [Published by Marketline] Prices from USD $175

NEXT ARTICLE

More From BioPortfolio on "Allergan plc Strategy, SWOT and Corporate Finance Report [Published by Marketline] Prices from USD $175"

Quick Search

Relevant Topics

Surgical treatments
Surgery is a technology consisting of a physical intervention on tissues. All forms of surgery are considered invasive procedures; so-called "noninvasive surgery" usually refers to an excision that does not penetrate the structure being exci...

Dermatology
Acne Dermatology Eczema Psoriasis Wound Care Dermatology is the medical specialty concerned with the diagnosis and treatment of skin disorders (Oxford Medical Dictionary). As well as studying how the skin works, dermatology covers...